Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Nature Medicine
Authors: Rocio Garcia-Carbonero, Roberto Pazo Cid, Teresa Macarulla, Berta Laquente, Alana Nguyen, Carmen Guillén-Ponce, Andrés Muñoz, Edward J. Kim, Mireya Cazorla, Tara Seery, Miriam Lobo de Mena, Chris Nevala-Plagemann, Vivek Sharma, Eva Martínez de Castro, Mohammad Hojouj, Charles Le, Ana Mato-Berciano, Sheila Connelly, Mike Kaleko, Luis A. Rojas, Vincent J. Wacher, Mary Ann Shallcross, Carmen Blasco, Manel Cascallo, Manuel Hidalgo
Institutions: Hospital Universitario 12 De Octubre, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Institut Català d'Oncologia, Duran i Reynals Hospital, Weill Cornell Medicine, Weill Cornell Medical Center, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, UC Davis Comprehensive Cancer Center, Hospital Clínico Universitario Virgen de la Victoria, Hoag Memorial Hospital Presbyterian, Hospital General Universitario De Valencia, University of Utah, Huntsman Cancer Institute, University of Louisville, Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla, University of Manchester, Simbec Research Ltd. (United Kingdom), Theriva Biologics (United States), NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7214909354